Literature DB >> 8550033

Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: separate evaluation of uptake and removal.

H Shinohara1, A Tanaka, T Kitai, N Yanabu, T Inomoto, S Satoh, E Hatano, Y Yamaoka, K Hirao.   

Abstract

We continuously measured hepatic absorbance of indocyanine green (ICG) using near-infrared (NIR) spectroscopy after intravenous bolus injection in rabbits. Hepatic ICG concentration was obtained by subtracting out the absorbance of hemoglobin and other pigments within the liver. Two exponential rate constants, the first reflecting the dye uptake from plasma to the hepatocytes, and the second representing the dye removal from the liver by cytoplasmic transport and biliary excretion, were determined by fitting the time-course curve of hepatic ICG concentration to a two-compartment model with irreversible transfer between the two compartments, as defined by the double-exponential equation: [ICG]liver(t) = -A exp(-alpha t) + B exp(-beta t). The results showed that treatment with bilirubin, a competitive inhibitor of ICG uptake, caused a decrease in alpha. Treatment with either colchicine, which is toxic to microtubules, or with ouabain, an inhibitor of Na+,K(+)-ATPase, caused a decrease in beta. These results were compatible with the kinetic model. This new method was then used in liver-injured rabbits inflicted with hemorrhagic shock and ischemia-reperfusion, to show that the first rate constant is primarily affected by hepatic microcirculatory condition, and the second refers closely to parenchymal liver damage. In another series of partial liver ischemia-reperfusions, it was possible to simultaneously and separately monitor the ICG profiles of post-ischemic and nonischemic areas. Thus, the kinetic analysis of hepatic ICG concentration curves, as directly measured by NIR spectroscopy, led to the separate evaluation of different clearance process of ICG in the liver, suggesting the advanced utility as a comprehensive liver function test.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550033     DOI: 10.1053/jhep.1996.v23.pm0008550033

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

1.  Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.

Authors:  Sophie E Boddington; Tobias D Henning; Priyanka Jha; Christopher R Schlieve; Lydia Mandrussow; David DeNardo; Harold S Bernstein; Carissa Ritner; Daniel Golovko; Ying Lu; Shoujun Zhao; Heike E Daldrup-Link
Journal:  Cell Transplant       Date:  2010       Impact factor: 4.064

2.  Neurotoxic effects of indocyanine green -cerebellar granule cell culture viability study.

Authors:  Beata Toczylowska; Elzbieta Zieminska; Grazyna Goch; Daniel Milej; Anna Gerega; Adam Liebert
Journal:  Biomed Opt Express       Date:  2014-02-19       Impact factor: 3.732

3.  A simulation study of the variability of indocyanine green kinetics and using structural a priori information in dynamic contrast enhanced diffuse optical tomography (DCE-DOT).

Authors:  Mehmet Burcin Unlu; Ozlem Birgul; Gultekin Gulsen
Journal:  Phys Med Biol       Date:  2008-05-27       Impact factor: 3.609

4.  Acceleration of dynamic fluorescence molecular tomography with principal component analysis.

Authors:  Guanglei Zhang; Wei He; Huangsheng Pu; Fei Liu; Maomao Chen; Jing Bai; Jianwen Luo
Journal:  Biomed Opt Express       Date:  2015-05-08       Impact factor: 3.732

5.  4-D reconstruction of fluorescence molecular tomography using re-assembled measurement data.

Authors:  Xin Liu; Xiaowe He; Zhuangzhi Yan; Hongbing Lu
Journal:  Biomed Opt Express       Date:  2015-05-06       Impact factor: 3.732

6.  Automatic selection of regularization parameters for dynamic fluorescence molecular tomography: a comparison of L-curve and U-curve methods.

Authors:  Maomao Chen; Han Su; Yuan Zhou; Chuangjian Cai; Dong Zhang; Jianwen Luo
Journal:  Biomed Opt Express       Date:  2016-11-09       Impact factor: 3.732

7.  In Vivo Pharmacokinetics Assessment of Indocyanine Green-Loaded Nanoparticles in Tumor Tissue with a Dynamic Diffuse Fluorescence Tomography System.

Authors:  Yanqi Zhang; Limin Zhang; Guoyan Yin; Wenjuan Ma; Jiao Li; Zhongxing Zhou; Feng Gao
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

Review 8.  Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?

Authors:  Andrea De Gasperi; Ernestina Mazza; Manlio Prosperi
Journal:  World J Hepatol       Date:  2016-03-08

9.  Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.

Authors:  Jinho Park; Yihua Pei; Hyesun Hyun; Mark A Castanares; David S Collins; Yoon Yeo
Journal:  J Control Release       Date:  2017-10-27       Impact factor: 9.776

10.  Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules.

Authors:  Jie Yu; David Javier; Mohammad A Yaseen; Nitin Nitin; Rebecca Richards-Kortum; Bahman Anvari; Michael S Wong
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.